Subscription and demo access

About Interfax
Press Releases
Products & Services
Contact us
Customer Login


07/20 15:37   Russia becomes cyber power, import substitution still needed - presidential envoy
07/20 15:32   Extended visa application form for British citizens developed on reciprocity basis - Russian Foreign Ministry
07/20 15:30   Official exchange rates for CIS and Baltic nations as of 20.07.2017
07/20 15:30   Lukoil increases number of board members
07/20 15:29   Moscow denies plans to host meeting between Armenian, Azerbaijani leaders, says venue not determined yet
07/20 15:27   Russia to demand extradition of blogger convicted in Azerbaijan
07/20 15:26   Moscow expects U.S. drills in Tajikistan to facilitate increase of region's stability level - Foreign Ministry
07/20 15:23   Aliyev declares Karabakh, Armenia 'historical Azeri lands'
07/20 15:22   Russian-U.S. talks on setting up cyber security working group under way - Russian president's envoy (Part 3)
07/20 15:20   Russia to verify reports on closure of CIA program backing Syrian opposition - Foreign Ministry  |  Interfax news  |  Pharmstandard, Millhouse close deal to acquire...

News headlines

July 25, 2014 09:25

Pharmstandard, Millhouse close deal to acquire stakes in Biocad Holding

MOSCOW. July 25 (Interfax) - Pharmstandard (MOEX: PHST), a major Russian drug maker, and Millhouse have completed individual acquisitions of shares in Biocad Holding Ltd., the principal shareholder of St. Petersburg-based biotech company CJSC Biocad, the companies said in a joint statement.

Pharmstandard acquired a 20% stake in Biocad Holding Ltd., while a company affiliated with Millhouse acquired 50%.

Pharmstandard financed the acquisition with its own money, the press release states.

Biocad CEO and founder Dmitry Morozov will retain a 30% stake in Biocad Holding Ltd and will continue to run the company with his management team, the statement said.

Biocad develops, manufactures and promotes its own and generic drugs to treat illnesses in the areas of urology, gynecology, dermatovenereology, oncology and hematology, as well as autoimmune and infectious diseases. The company has a line of 14 drugs.

"Millhouse and Pharmstandard have a successful track record of working together to develop leaders in the pharmaceutical market. The companies previously cooperated on the acquisitions of ICN Pharmaceuticals, Inc. and CJSC Masterlek, and on Pharmstandard's initial public offering," the press release said.

It was reported earlier that in this deal the companies would buy the stake of Gazprombank (MOEX: GZPR), which acquired a controlling stake in the pharmaceutical company in 2011 for about $250 million-$300 million, as well as part of the stake held by company management.

RMG senior analyst Ksenia Arutyunova valued all of Biocad at $1 billion. Therefore, the stakes acquired by Pharmstandard and Millhouse are worth $200 million and $500 million respectively.

Millhouse is acting as a financial investor, who will divest the stake at some point, Arutyunova said, adding that this stake could be bought by Pharmstandard.

Biocad currently sells its products in Russia and other CIS countries. The company has offices in Ukraine, Belarus, Brazil, China, India and the United States. Biocad is also setting up production of drugs based on monoclonal antibodies in Brazil.

Biocad has two factories in Russia - in the Moscow Region and in the St. Petersburg special economic zone. The company had revenue of 3 billion rubles in 2013.

It was reported earlier that U.S. drug makers Pfizer and Amgen were interested in buying Biocad. The company was valued at $0.75 billion-$1 billion.

Vp of

(Our editorial staff can be reached at

You can access a demo version of, receive more information about or subscribe to Interfax publications by filling in and returning the form below. We also have dozens of reports in the Russian language, please indicate if you are interested.



First name:


Last name:


Central Asia & Caucasus Business Weekly
Central Asia General Newswire
Global Gas Analytics
Global Natural Gas Daily
Interfax Via Bloomberg Terminal
Kazakhstan General Newswire
Kazakhstan Mining Weekly
Kazakhstan Oil & Gas Weekly
Russia & CIS Announcements
Russia & CIS Banking and Finance Weekly
Russia & CIS Business and Financial Daily
Russia & CIS Business and Financial Newswire
Russia & CIS Business and Investment Weekly
Russia & CIS Business Law Weekly
Russia & CIS Business news
Russia & CIS Defense Industry Weekly
Russia & CIS Diplomatic Panorama
Russia & CIS Energy Daily
Russia & CIS Energy Newswire
Russia & CIS Events Calendar
Russia & CIS Food and Agriculture Weekly
Russia & CIS General Newswire
Russia & CIS Headline News
Russia & CIS Insurance Weekly
Russia & CIS IT and Telecom Weekly
Russia & CIS Metals and Mining Weekly
Russia & CIS Military Daily
Russia & CIS Military Newswire
Russia & CIS Military Weekly
Russia & CIS Oil and Gas Weekly
Russia & CIS Presidential Bulletin
Russia & CIS Statistics Weekly
Russia Health & Pharmaceuticals
Russia Market Roundup
Russia Press Review
Ukraine Business Daily
Ukraine Business Weekly
Ukraine General Newswire
Please enter the digits from picture in the box below:

July 20, 2017
Aliyev declares Karabakh, Armenia 'historical Azeri lands'
Russian-U.S. talks on setting up cyber security working group under way - Russian president's envoy (Part 3)
OSCE on anniversary of Sheremet murder calls on Kyiv to end impunity of journalists killers
Drop in Philip Morris Russian sales slows to 4.7% in Q2
Moscow seeks Washington's clarification of reports on extension of Bout's sentence - Foreign Ministry
Int'l arbitration panel in Arctic Sunrise case encourages unlawful actions in Arctic - Russian Foreign Ministry (Part 2)
Putin congratulates Moscow Helsinki Group leader Alekseyeva in person on her 90th birthday
MICEX and RTS Indexes at 15:00 MSK
Rogozin to visit Moldova although he wasn't allowed to come aboard Russian Aerospace Forces plane
Sberbank appeals ruling in Transneft lawsuit over derivatives - court materials (Part 2)
Investigators believe 'Russian connection' in Sheremet killing is highly probable - Ukrainian Interior Ministry
S-400 missile systems to be delivered to China on time, in line with contract - Rosoboronexport
 more headlines 


Secretary General of the League of Arab States has given an interview with Interfax in the wake of his negotiations with Russian Foreign Minister Sergei Lavrov in which he speaks about the participation of Arab countries in the Astana process, Russia‘s political and military role in Syria, as well as prospects for resuming Syria‘s membership in the Arab League.

Bahraini Ambassador to Russia Ahmed Abdulrahman Al Saati has given an interview to Interfax in which he speaks about the prolongation of the decision of OPEC and non-OPEC countries to freeze oil output, prospects of energy cooperation between Bahrain and Russia, bilateral military-technical cooperation and prospects for resuming diplomatic relations with Iran.

Following strikes of the U.S.-led coalition on pro-governmental forces in Syria, the coalitions spokesman Ryan Dillon has given a Skype interview to Interfaxs correspondent Ksenia Baygarova in which he speaks about if U.S. notified Russia in advance of upcoming strikes on pro-governmental forces in Syria, about how to avoid incidents in the future and about when al-Raqqa and Mosul will be liberated from terrorists.


 ©   1991—2017   Interfax Information Service. All rights reserved.
contact information   |   Interfax offices   |   made by web.finmarket

News and other data on this site are provided for information purposes only, and are not intended for republication or redistribution. Republication or redistribution of Interfax content, including by framing or similar means, is expressly prohibited without the prior written consent of Interfax.

Browse other Interfax sites:   |   IFX.RU   |   Interfax Group   Rambler's Top100